Nicotinamide Riboside

A well-studied NAD+ precursor with real human trials on safety and blood NAD+ levels

Reliably raises blood NAD+ in controlled trials

Well tolerated up to 1,000mg/day in trials

Important: These statements have not been evaluated by the FDA. This information is not intended to diagnose, treat, cure, or prevent any disease. Always consult your physician before starting any supplement.

Overview

Nicotinamide Riboside (NR) is a form of vitamin B3 and one of two popular precursor molecules — the other being NMN — that your body converts into NAD+, a coenzyme every cell needs to produce energy and repair DNA. NAD+ levels decline measurably with age, and the premise behind NR supplementation is straightforward: replenish the raw material to help restore more youthful NAD+ levels.

NR has one of the more mature human research bases in the "longevity supplement" category, including a well-designed long-term safety and dosing trial. What it hasn't been shown to do — and what no NAD+ precursor has been shown to do — is extend human lifespan; that evidence exists only in mice so far. It's best understood as a well-tolerated, biomarker-backed metabolic support supplement, not a proven anti-aging treatment.

Potential Benefits

Raises Blood NAD+ Levels

A randomized, placebo-controlled crossover trial found NR reliably and significantly raised blood NAD+ in healthy middle-aged and older adults.

Well-Established Safety Profile

An 8-week dose-ranging trial found doses up to 1,000mg/day well tolerated, with no significant increase in adverse events versus placebo.

No Adverse Cholesterol Effect

The same dose-ranging trial found NR did not elevate LDL cholesterol or disrupt related metabolic markers, even at the highest dose tested.

GRAS-Recognized Ingredient

Recognized as Generally Recognized as Safe (GRAS) by the FDA for use in food products, reflecting a favorable regulatory safety review.

Typical Dosage

Standard Daily Dose

250–500mg per day

Trials found dose-dependent NAD+ increases at 100mg, 300mg, and 1,000mg

Trial-Tested Upper Range

Up to 1,000mg per day

Well tolerated in an 8-week randomized trial, though this is not necessarily the most cost-effective dose

Pro Tips

Treat it as metabolic-support, not a proven longevity guarantee — the human evidence supports raised NAD+, not extended lifespan
Take with or without food — trials haven't shown a meaningful absorption difference either way
Don't pay a premium for "proprietary" NR forms without independently verified human data behind the specific claim
Talk to your doctor before starting, especially if you're on other medications, since long-term data beyond several months is still limited

Research Snapshot

An 8-week randomized, double-blind, placebo-controlled trial in healthy overweight adults found that 100mg, 300mg, and 1,000mg daily doses of NR dose-dependently raised whole blood NAD+ by 22%, 51%, and 142% respectively, with no significant difference in adverse events between NR and placebo groups and no negative effect on LDL cholesterol. A separate crossover trial in healthy middle-aged and older adults confirmed NR was well tolerated and effectively raised blood NAD+ levels.

Source: Conze et al., Scientific Reports (2019)

How Nicotinamide Riboside Compares

Ingredient	Best For	Key Difference
Nicotinamide Riboside	NAD+ Support, Longest Human Track Record	Most human trial data of the NAD+ precursors
NMN	NAD+ Support, Metabolic Function	One fewer conversion step to NAD+; a trial found improved muscle insulin sensitivity
Resveratrol	Sirtuin Activation Support	Often paired with NAD+ precursors, though human co-supplementation data is limited
CoQ10	Cellular Energy, Different Pathway	Supports mitochondrial energy production via a separate mechanism from NAD+

These are the most common comparisons our customers ask about in-store.

Popular Stacks with Nicotinamide Riboside

Cellular Energy Stack

Nicotinamide Riboside + CoQ10 + Resveratrol

Targets mitochondrial energy production from multiple angles

Longevity Foundation Stack

Nicotinamide Riboside + Omega-3 + Vitamin D3

Pairs NAD+ support with broadly evidence-backed healthy-aging basics

Metabolic Support Stack

Nicotinamide Riboside + Berberine + Magnesium

Combines NAD+ support with established metabolic-health ingredients

Frequently Asked Questions

What's the difference between Nicotinamide Riboside and NMN?

Both are precursor molecules your body converts into NAD+, just at slightly different points in the same pathway — NMN is actually one step closer to NAD+ than NR. In practice, NR has the longer track record of well-controlled human trials confirming it reliably raises blood NAD+ levels and is well tolerated at doses up to 1,000mg. Neither has a decisively proven edge over the other in humans.

Is Nicotinamide Riboside safe to take long-term?

The available human data is reassuring: an 8-week randomized trial found doses up to 1,000mg/day were well tolerated with no significant difference in adverse events versus placebo, and no negative impact on cholesterol or liver-related metabolic markers. It's also recognized as Generally Recognized as Safe (GRAS) by the FDA. Long-term data beyond several months in humans is still limited.

Does Nicotinamide Riboside actually help you live longer?

No human trial has tested, or could realistically test on a near-term timeline, whether NR extends human lifespan. The evidence for a longevity effect currently comes from mouse studies. What's proven in humans is that it safely and reliably raises blood NAD+ levels — a real, measurable outcome, just not the same claim as "you'll live longer."

Sources & References

1. Martens, C.R., Denman, B.A., Mazzo, M.R., et al. (2018). Chronic nicotinamide riboside supplementation is well-tolerated and elevates NAD+ in healthy middle-aged and older adults. Nature Communications, 9(1), 1286.

2. Conze, D., Brenner, C., & Kruger, C.L. (2019). Safety and metabolism of long-term administration of NIAGEN (nicotinamide riboside chloride) in a randomized, double-blind, placebo-controlled clinical trial of healthy overweight adults. Scientific Reports, 9, 9772.

All references are peer-reviewed studies or position stands from reputable organizations.